Preemptive therapy versus universal prophylaxis: Time for reconciliation?

被引：2
|
作者：
Kampouri, Eleftheria [1 ]
Manuel, Oriol [2 ,3 ,4 ,5 ]
机构：
[1] Fred Hutchinson Canc Ctr, Vaccine & Infect Dis Div, Seattle, WA USA
[2] Lausanne Univ Hosp, Infect Dis Serv & Transplantat Ctr, Lausanne, Switzerland
[3] Univ Lausanne, Lausanne, Switzerland
[4] Lausanne Univ Hosp, Infect Dis Serv & Transplantat Ctr, BH10-549,Bugnon 46, CH-1011 Lausanne, Switzerland
[5] Univ Lausanne, BH10-549,Bugnon 46, CH-1011 Lausanne, Switzerland
来源：
TRANSPLANT INFECTIOUS DISEASE | 2023年 / 25卷 / 02期
关键词：
ONSET CYTOMEGALOVIRUS DISEASE; LIVER-TRANSPLANT RECIPIENTS; ANTIVIRAL PROPHYLAXIS;
D O I：
10.1111/tid.14014
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Preemptive therapy versus universal prophylaxis with ganciclovir for cytomegalovirus in solid organ transplant recipients
    Singh, N
    CLINICAL INFECTIOUS DISEASES, 2001, 32 (05) : 742 - 751
  • [2] Evaluation of Universal versus Preemptive Antifungal Prophylaxis in Lung Transplantation
    Logan, A. T.
    Brenner, A.
    Sullivan, J.
    Patel, K.
    Sharma, N.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2020, 39 (04): : S213 - S214
  • [3] PREEMPTIVE THERAPY VERSUS UNIVERSAL PROPHYLAXIS WITH VALGANCICLOVIR IN MINIMIZING THE RISK OF CYTOMEGALOVIRUS DISEASE IN KIDNEY TRANSPLANT RECIPIENTS
    Khan, Muhammad
    TRANSPLANT INTERNATIONAL, 2019, 32 : 295 - 295
  • [4] Universal Prophylaxis, Targeted Prophylaxis, and/or Preemptive Therapy for Opportunistic Infections at the Time of Initiation of Combination Antiretroviral Therapy for Patients with Advanced HIV Infection
    DiNubile, Mark J.
    CLINICAL INFECTIOUS DISEASES, 2009, 49 (05) : 808 - U168
  • [5] PREEMPTIVE THERAPY VERSUS UNIVERSAL PROPHYLAXIS WITH VALGANCICLOVIR IN MINIMIZING THE RISK OF CYTOMEGALOVIRUS DISEASE IN KIDNEY TRANSPLANT RECIPIENTS
    Khan, Muhammad Tassaduq
    SWISS MEDICAL WEEKLY, 2019, : 19S - 19S
  • [6] Universal Prophylaxis, Targeted Prophylaxis, and/or Preemptive Therapy for Opportunistic Infections at the Time of Initiation of Combination Antiretroviral Therapy for Patients with Advanced HIV Infection Reply
    Srasuebkul, Preeyaporn
    Sungkanuparph, Somnuek
    Lim, Poh Lian
    Law, Matthew G.
    CLINICAL INFECTIOUS DISEASES, 2009, 49 (05) : 811 - U170
  • [7] Cost Effectiveness Analysis of Universal Prophylaxis Versus Preemptive Therapy in Kidney Transplant Patients with Positive Cytomegalovirus Serology
    Luan, Fu L.
    Kommareddi, Mallika
    Ojo, Akinlolu O.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2010, 10 : 126 - 126
  • [8] Prophylaxis followed by preemptive therapy versus preemptive therapy for prevention of human cytomegalovirus disease in pediatric patients undergoing liver transplantation
    Gerna, Giuseppe
    Lilleri, Daniele
    Callegaro, Annapaola
    Goglio, Antonio
    Cortese, Serena
    Stroppa, Paola
    Torre, Giuliano
    TRANSPLANTATION, 2008, 86 (01) : 163 - 166
  • [9] Post-transplant cytomegalovirus (CMV) infection: Prophylaxis versus preemptive therapy
    Mangino, M.
    Maiorano, A.
    Schena, A.
    Ditonno, P.
    Battaglia, M.
    Palazzo, S.
    Schena, F. P.
    Grandaliano, G.
    TRANSPLANT INTERNATIONAL, 2007, 20 : 246 - 246
  • [10] A Randomized Trial of Valganciclovir Prophylaxis Versus Preemptive Therapy in Kidney Transplant Recipients
    Reischig, Tomas
    Vlas, Tomas
    Kacer, Martin
    Pivovarcikova, Kristyna
    Lysak, Daniel
    Nemcova, Jana
    Drenko, Petr
    Machova, Jana
    Bouda, Mirko
    Sedivcova, Monika
    Kormunda, Stanislav
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2023, 34 (05): : 920 - 934
12345